Castle Biosciences CFO Frank Stokes Honored in Houston Business Journal's 2026 CFO Awards
Event summary
- Frank Stokes, Castle Biosciences' CFO since December 2017, named a 2026 CFO Awards honoree by the Houston Business Journal.
- Stokes recognized among 22 financial leaders in Greater Houston for financial leadership and organizational contributions.
- Honorees to be celebrated at an awards event on July 30, 2026, and featured in the July 31 print and digital editions of the Houston Business Journal.
- Stokes previously named a Top 25 CFO of Houston by TOP CFOs in 2024.
The big picture
Frank Stokes' recognition underscores the importance of financial leadership in guiding Castle Biosciences through significant milestones, including its IPO and strategic acquisitions. This award highlights the company's focus on disciplined financial management amid a competitive diagnostics landscape. The honor also reflects broader industry trends where CFOs are increasingly valued for their strategic roles beyond traditional financial oversight.
What we're watching
- Leadership Stability
- Whether Frank Stokes' continued recognition reflects sustained financial discipline and strategic vision at Castle Biosciences.
- Strategic Growth
- How the company's growth through multiple strategic acquisitions will be supported under Stokes' leadership.
- Market Positioning
- The pace at which Castle Biosciences can maintain its leading position in dermatologic and gastroenterological diagnostics.